Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
2 clinical trials · Condition
◉ Watch Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma (NCT07691450) | City of Hope Medical Center | 2027-01-03 |
| Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma (NCT04795869) | Northwestern University | 2020-03-01 |
Track Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.